CapsoVision, Inc
CapsoVision, Inc. is a global commercial-stage medical technology company focused on developing advanced imaging and artificial intelligence technologies to create diagnostic and screening products for identifying abnormalities of the gastrointestinal tract. The company operates as a Delaware corporation incorporated… From the company’s description.
Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.
What CapsoVision, Inc does
In the company’s own words
CapsoVision, Inc. is a global commercial-stage medical technology company focused on developing advanced imaging and artificial intelligence technologies to create diagnostic and screening products for identifying abnormalities of the gastrointestinal tract. The company operates as a Delaware corporation incorporated in 2005 with headquarters in Saratoga, California.
The company's core product portfolio centers on its GI-tract capsule endoscopy solution, which comprises single-use CapsoCam capsules paired with associated software platforms CapsoCloud and CapsoView. CapsoCam Plus, the company's flagship product for small bowel visualization, received FDA 510(k) clearance in 2016 and began U.S. commercial sales in 2017. As of December 31, 2025, CapsoCam Plus has been used in more than 161,000 patients globally. For the years ended December 31, 2025 and 2024, the company generated approximately $13.6 million and $11.8 million in revenue, respectively, with international sales representing 21 percent of total revenue in 2025.
CapsoVision's differentiated technology features a proprietary 360-degree panoramic view capturing complete gastrointestinal mucosa visualization, contrasting with competitors' limited end-view systems. The company's capsules operate as wire-free, zero-capital-expenditure solutions storing video in onboard memory, with cloud-based analysis capabilities enabling remote provider access and telemedicine supervision following FDA clearance in December 2024.
The company's pipeline includes CapsoCam Colon, designed for colorectal polyp detection and measurement incorporating automated AI-driven pathology detection and proprietary 3D-sensing technology for polyp sizing. Following FDA feedback on its first-generation submission, CapsoVision is developing an improved second-generation CapsoCam Colon with enhanced imaging quality and expanded field of view, targeting FDA 510(k) submission in the third quarter of 2026.
Additional development initiatives include a capsule delivery device for patients unable to swallow capsules, a patency capsule for Crohn's disease patients, and exploratory studies for esophageal and pancreatic cancer detection applications. The company maintains over 140 issued patents covering multiple aspects of its capsule technology and platforms. CapsoVision's research and development team comprises hardware and software engineers specializing in medical technology, optics, data science, artificial intelligence, and cloud-based architecture.
Company details
- Sector
- Healthcare
- Industry
- Electromedical Apparatus
- Headquarters
- SARATOGA, CA
- Fiscal year end
- December
- CIK
- 1378325
- SIC
- 3845
Financial performance, year by year
Fiscal 2025–2025 · USDThe full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.
Who owns CapsoVision, Inc — and what changed
Funds as of 2026Q2 · superinvestors as of 2026-06-30
Largest fund holders · CapsoVision, Inc’s weight in each
Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.
Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.
Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.
Recent filings
All filings →Each filing opens into its own statements and disclosures here.
Put this business in context.
Compare this company with peers, find it in your funds and follow its financial history with your connected AI:
- “How do CapsoVision, Inc and its peers compare on margins and cash generation over ten years?”
- “Where did five years of CapsoVision, Inc's earnings go — cash, debt, buybacks, reinvestment?”
- “What changed in CapsoVision, Inc's last four quarterly filings that the numbers alone won't show?”